DaVita

DaVita Inc.

DaVita Inc.'s headquarters as seen from the Denver Millennium Bridge
Company type	Public
Traded as	NYSE: DVA S&P 500 component
Industry	Healthcare
Founded	1979; 45 years ago (1979)
Headquarters	Denver, Colorado, U.S.
Key people	Javier J. Rodriguez (CEO)
Services	Kidney dialysis
Revenue	US$12.140 billion (2023)
Operating income	US$1.602 billion (2023)
Net income	US$956 million (2023)
Total assets	US$16.893 billion (2023)
Total equity	US$1.244 billion (2023)
Owner	Berkshire Hathaway (41.2%)[1]
Number of employees	70,000 (2023)
Website	davita.com
Footnotes / references [2]

DaVita Inc. provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver.^[2]

In 2023, 67% of the company's revenues came from Medicare and other government-based health insurance programs. In 2023, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 33% of revenues in 2023, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.^[2]

The company is ranked 341st on the Fortune 500.^[3]

The name "DaVita" was derived from the Italian language phrase "Dare Vita", which means "to give life".^[4]